News
The British drug agency is monitoring a possible increase in cases of the disease, although there is no data yet to warrant ...
Dizal has received FDA approval for Zegfrovy to treat adults with locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations.
The new system replaces pass/fail grades with a more practical approach that categorizes violations based on actual health ...
1hon MSN
At recent prices, the yield you receive from Pfizer is more than four times the amount you'd receive from the average ...
20mon MSN
Inappropriate polypharmacy—the excessive or unnecessary use of multiple medications—is a major driver of emergency hospital ...
Asahi Kasei Pharma begins phase III study of promising CIPN prevention therapy, Recomodulin to enhance treatment options worldwide: Chelmsford, Massachusetts Thursday, July 3, 202 ...
21m
Dear Media on MSNExploring The Body Positivity-to-Ozempic Pipeline: How Did We Get Here? - Dear MediaScroll back to the halcyon days of 2020, when the Internet was overflowing with self-love sermons, plus-size runway shows, and pastel infographics reminding us to “embrace every curve.” Now ...
12m
TAG24 on MSNUS researchers find cancer’s secret weapon to defeat deathFat isn’t just a guilty pleasure — it’s cancer’s secret weapon. New research from UT Southwestern Medical Center is shedding light on why this is the case.In a study published this month in the ...
Returning as the industry’s definitive forum from early discovery to clinical development, the 8th Annual TPD & Induced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results